GALA PHARMACEUTICAL INC. (OTCMKTS: GLPH) Files An 8-K Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers

GALA PHARMACEUTICAL INC. (OTCMKTS: GLPH) Files An 8-K Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers
ITEM 5.02. DEPARTURE OF DIRECTORS OR PRINCIPAL OFFICERS; ELECTION OF DIRECTORS; APPOINTMENT OF PRINCIPAL OFFICERS

Story continues below

Ms. Allison Hess resigned as an officer and director with the Company effective as of November 30, 2018. The resignation was not the result of any disagreement with the Company on any matter relating to the Company’s operations, policies or practices.

On November 30, 2018, Mr. Maqsood Rehman was appointed as a member of the Company’s Board of Directors and as the Company’s Chief Financial Officer, Secretary and Treasurer and Director for the Corporation. Mr. Rehman is currently the Corporation’s Chief Executive Office.

The biography for Mr. Maqsood Rehman is set forth below:

Dr. Maqsood Rehman, is currently CEO of Gala Pharmaceutical, Inc. (“GLPH”) where he was the COO since June 2017. Prior to GLPH, Mr. Rehman was the Global Soybean Breeding Leader for Dow Agrosciences at Indianapolis, Indiana for six years. Previously, he worked as a soybean breeder for Monsanto Company at Oxford, Indiana for five years. Maqsood Rehman has Masters and PhD degrees in Plant Science from University of Idaho, U.S.A. and Post Doctorate from University of Missouri-Columbia, Missouri. He has a diversified scientific background with training, and 10 plus years of practical experience in plant breeding, quantitative and molecular genetics and cytogenetics and project management.

Dr. Rehman’s experience ranges from providing leadership to the breeding organization to developing breeding strategies and budgets needed to accomplish breeding goals. He fills in the gaps by bringing key stakeholders together and aligns breeding goals with global commercial needs through effective communication. He is also an expert at developing teams and providing effective and transparent communication process to achieve deliverables.

Item 9.01 Financial Statements and Exhibits

(d) Exhibits.

Exhibit No. Exhibit
Resignation of Allison Hess


Gala Pharmaceutical Inc. Exhibit
EX-17 2 gala_8k-ex0017.htm RESIGNATION OF ALLISON HESS   Exhibit 17     RESIGNATION   TO: GALA PHARMACEUTICAL,…
To view the full exhibit click here

An ad to help with our costs